Sponsor intelligence · OTHER
Clinical trials sponsored by
Nanjing First Hospital, Nanjing Medical University.
Real, source-linked trial activity for Nanjing First Hospital, Nanjing Medical University: 5 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Nov 6, 2026. Source-linked, daily-refreshed.
N/A 4PHASE3 1
Newest Nanjing First Hospital, Nanjing Medical University trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 2d ago | 68Ga-labeled Cholecystokinin Receptor (CCK2R) Targeted Molecular Probe | N/A | RECRUITING | ↗ |
| 4d ago | Cholecystectomy, Biliary Diseases, and Colorectal Adenoma Risk: A Real | N/A | ACTIVE_NOT_RECRUITING | ↗ |
| 8d ago | Keverprazan-Minocycline Dual Therapy of Different Durations Versus Bis | Ph 3 | RECRUITING | ↗ |
| 46d ago | AI-CCTA for Predicting Cardiovascular Events in CAD | N/A | ACTIVE_NOT_RECRUITING | ↗ |
| 59d ago | A Comparative Study Protocol Investigating the Association Between Int | N/A | COMPLETED | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Nanjing First Hospital, Nanjing Medical University (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.